CVS Health Corp | CVS | Long at $61.00NYSE:CVS Health Corp will need a revision to its business model in order to survive an ever-changing retail/pharmacy environment. However, with a P/E of 10x, debt-to-equity of less than 1x, growing cash flow, and dividend yield of 4.3%, the stock seems quite undervalued. Perhaps activist investors will soon step in, but if history repeats, there may be a nice bounce ahead as the price consolidates in the GETTEX:50S and low $60s. Thus, near its current price of $61, NYSE:CVS is in a personal buy zone.
Target #1 = $66.00
Target #2 = $68.00
Target #3 = $75.00
Target #4 = $79.00
Cvshealth
CVS Health Corporation Options Ahead of EarningsAnalyzing the options chain and the chart patterns of CVS Health Corporation prior to the earnings report this week,
I would consider purchasing the 75usd strike price Calls with
an expiration date of 2024-2-9,
for a premium of approximately $1.00.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
CVS Health Corporation Options Ahead of EarningsAnalyzing the options chain and the chart patterns of CVS Health Corporation prior to the earnings report this week,
I would consider purchasing the 75usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $2.55.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.